These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9009250)

  • 1. Enhanced delivery of synthetic oligonucleotides to human leukaemic cells by liposomes and immunoliposomes.
    Ma DD; Wei AQ
    Leuk Res; 1996; 20(11-12):925-30. PubMed ID: 9009250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel antisense therapeutics delivery systems: In vitro and in vivo studies of liposomes targeted with anti-CD20 antibody.
    Meissner JM; Toporkiewicz M; Czogalla A; Matusewicz L; Kuliczkowski K; Sikorski AF
    J Control Release; 2015 Dec; 220(Pt A):515-528. PubMed ID: 26585505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anti-HIV activity of thiocholesteryl-coupled phosphodiester antisense oligonucleotides incorporated into immunoliposomes.
    Zelphati O; Wagner E; Leserman L
    Antiviral Res; 1994 Sep; 25(1):13-25. PubMed ID: 7811058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and effects of immunoliposomes carrying an antisense oligonucleotide against DHFR RNA and directed toward human breast cancer cells overexpressing HER2.
    Rodríguez M; Coma S; Noé V; Ciudad CJ
    Antisense Nucleic Acid Drug Dev; 2002 Oct; 12(5):311-25. PubMed ID: 12477281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future directions of liposome- and immunoliposome-based cancer therapeutics.
    Park JW; Benz CC; Martin FJ
    Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal delivery of oligodeoxynucleotides.
    Tari A; Khodadadian M; Ellerson D; Deisseroth A; Lopez-Berestein G
    Leuk Lymphoma; 1996 Mar; 21(1-2):93-7. PubMed ID: 8907275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV replication by immunoliposomal antisense oligonucleotide.
    Selvam MP; Buck SM; Blay RA; Mayner RE; Mied PA; Epstein JS
    Antiviral Res; 1996 Dec; 33(1):11-20. PubMed ID: 8955849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugs.
    Connor J; Huang L
    Cancer Res; 1986 Jul; 46(7):3431-5. PubMed ID: 2871923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of diphtheria toxin A fragment to toxin-resistant murine cells delivered by pH-sensitive immunoliposomes.
    Collins D; Huang L
    Cancer Res; 1987 Feb; 47(3):735-9. PubMed ID: 3802078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of the activation and collagen production of cultured rat hepatic stellate cells by antisense oligonucleotides against transforming growth factor-beta 1 is enhanced by cationic liposome delivery].
    Liu X; Zhang Z; Yang L; Chen D; Wang Y
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):133-5, 142. PubMed ID: 12515114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoliposomes with different acid sensitivities as probes for the cellular endocytic pathway.
    Collins D; Maxfield F; Huang L
    Biochim Biophys Acta; 1989 Dec; 987(1):47-55. PubMed ID: 2597686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of in vivo stability of phosphodiester oligonucleotide using anionic liposomes in mice.
    De Oliveira MC; Boutet V; Fattal E; Boquet D; Grognet JM; Couvreur P; Deverre JR
    Life Sci; 2000 Aug; 67(13):1625-37. PubMed ID: 10983856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.
    Pagnan G; Stuart DD; Pastorino F; Raffaghello L; Montaldo PG; Allen TM; Calabretta B; Ponzoni M
    J Natl Cancer Inst; 2000 Feb; 92(3):253-61. PubMed ID: 10655443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of anti-EGFR immunoliposomes via folate-folate binding protein affinity.
    Pan X; Lee RJ
    Int J Pharm; 2007 May; 336(2):276-83. PubMed ID: 17212981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the Friend retrovirus by antisense oligonucleotides encapsulated in liposomes: mechanism of action.
    Ropert C; Malvy C; Couvreur P
    Pharm Res; 1993 Oct; 10(10):1427-33. PubMed ID: 8272403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes.
    Fattal E; Couvreur P; Dubernet C
    Adv Drug Deliv Rev; 2004 Apr; 56(7):931-46. PubMed ID: 15066753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target-sensitive immunoliposomes as an efficient drug carrier for antiviral activity.
    Ho RJ; Rouse BT; Huang L
    J Biol Chem; 1987 Oct; 262(29):13973-8. PubMed ID: 2820987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities.
    Brignole C; Marimpietri D; Pagnan G; Di Paolo D; Zancolli M; Pistoia V; Ponzoni M; Pastorino F
    Cancer Lett; 2005 Oct; 228(1-2):181-6. PubMed ID: 15936140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation of cationic liposomes and its role in enhancing cellular uptake of antisense oligonucleotides].
    Chen HL; Liang WQ; Shao JB; Chen Z
    Yao Xue Xue Bao; 2004 Jan; 39(1):72-6. PubMed ID: 15127587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal targeting of bcl-2 antisense oligonucleotides with enhanced stability into human myeloma cell lines.
    Ollikainen H; Lappalainen K; Jääskeläinen I; Syrjänen S; Pulkki K
    Leuk Lymphoma; 1996 Dec; 24(1-2):165-74. PubMed ID: 9049973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.